Screener
Rhythm Pharmaceuticals, Inc. RYTM Stock Issuance Proceeds
Stock Issuance Proceeds at other companies
Other financials
Where this comes from
Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfCommonStock.
The source filing: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-030549
| Line item | Three months ended March 31, 2026 | Three months ended March 31, 2025 |
|---|---|---|
| Proceeds from the exercise of stock options | 6,095 | 2,226 |
| Tax withholding on vesting of restricted stock | (8,458) | — |
| Proceeds from issuance of common stock from ESPP | 1,251 | 854 |
| Proceeds from ATM equity offering | — | 34,034 |
| Net cash (used in) provided by financing activities | (5,400) | 32,499 |
| Effect of exchange rates on cash | 448 | (2) |
| Net increase in cash, cash equivalents and restricted cash | 7,915 | 16,958 |
| Cash, cash equivalents and restricted cash at beginning of period | 54,823 | 89,601 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Rhythm Pharmaceuticals, Inc.'s stock issuance proceeds?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported stock issuance proceeds of $0 in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s stock issuance proceeds changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s stock issuance proceeds decreased by 100.0% year-over-year, from $34.03M to $0.
- What does stock issuance proceeds mean?
- Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.
Ask your AI about Rhythm Pharmaceuticals, Inc.'s stock issuance proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude